Stephen F Mahoney Net Worth & Insider Trades
Stephen F Mahoney - See Remarks, Magenta Therapeutics, Inc
What is Stephen F Mahoney's Net Worth?
The current estimated net worth of Magenta Therapeutics, Inc's See Remarks, Stephen F Mahoney, is estimated to be about $979.22K . Stephen F Mahoney owns about 14,264 units of Magenta Therapeutics, Inc common stock. In the last 2 years at Magenta Therapeutics, Inc, Stephen F Mahoney has sold an estimated value of $38.6K worth.
What is Stephen F Mahoney's Past Insider Trading?
Stephen F Mahoney's largest sale order was 5,736 units , worth over $38.6K on September 20, 2021. In total, Stephen F Mahoney has made about 7 transactions over 2 years of their time at Magenta Therapeutics, Inc. Stephen F Mahoney usually trades in September, with the busiest year in 2022.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Stephen F Mahoney
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Stephen F Mahoney's Salary in 2020?
As See Remarks of Magenta Therapeutics, Inc, Stephen F Mahoney has a total base salary of $70,000 . Stephen F Mahoney received compensation valued at about $1,959,130 in 2020 after becoming See Remarks. The vast majority of their compensation came in the form of option awards of $1,888,655 , other compensation of $475 .
What is Stephen F Mahoney's' Mailing Address?
- Mailing address is C/o Kiniksa Pharmaceuticals, Ltd. Clarendon House, 2 Church Street Hamilton D0 HM11 Bermuda
Magenta Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Jason Gardner, D.Phil. | 2020 | $530,000 | - | $2,309,592 | $262,000 | $1,256 | $3,102,848 |
| Jason Gardner, D.Phil. | 2019 | $515,000 | - | $903,764 | $231,750 | $487 | $1,651,001 |
| John C. Davis, Jr., M.D. | 2020 | $445,376 | - | $1,153,528 | $162,000 | $1,256 | $1,762,160 |
| John C. Davis, Jr., M.D. | 2019 | $417,000 | - | $345,899 | $150,120 | $502 | $913,521 |
| Stephen F. Mahoney | 2020 | $70,000 | - | $1,888,655 | - | $475 | $1,959,130 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1690585/000119312521123656/d32109ddef14a.htm
What are Magenta Therapeutics, Inc's Past Insider Trades?
Magenta Therapeutics, Inc's most recent insider trade came on February 9, 2023 by Third Rock Ventures Iv Lp, Third Rock Ventures GP Iv Lp and Trv GP Iv Llc who sold 3,700,000 units worth $3.06M . In the last 5 years, insiders at Magenta Therapeutics, Inc have sold an estimated value of $7.27M and bought an estimated value of $10.45M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Jason Gardner, See Remarks, Michael P Cooke, Chief Scientific Officer, and Kristen Stants, Chief People Officer .
Magenta Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||